ask="6.00"
ask_size="1500"
average_daily_volume="941631"
bid="5.51"
bid_size="500"
book_value="0.05"
change="-0.34"
change_from_200_day_moving_average="0.56"
change_from_50_day_moving_average="-0.58"
change_from_52_week_high="-1.90"
change_From_52_week_low="3.92"
change_in_percent="-5.67%"
close="5.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42554000"
high="6.00"
high_52_weeks="7.56"
last_trade_date="2/10/2017"
last_trade_price="5.66"
last_trade_size="20569"
last_trade_time="4:00pm"
low="5.58"
low_52_weeks="1.74"
market_capitalization="417.47M"
moving_average_200_day="5.10"
moving_average_50_day="6.24"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.00"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+11.07%"
percent_change_from_50_day_moving_average="-9.23%"
percent_change_from_52_week_high="-25.13%"
percent_change_from_52_week_low="+225.29%"
previous_close="6.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="111.11"
price_per_sales="20.14"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="6.39"
stock_exchange="NMS"
symbol="BCRX"
volume="778144"
weeks_range_52="1.74 - 7.56"
